Neoadjuvant Chemotherapy for High Grade Myxoid Liposarcoma

Some answers, more questions

Feb 19, 2024 • 

Brian Schulte

1

December 2023

Sarcoma Cellular Therapeutics Initiative

Making Something New

Dec 15, 2023 • 

Brian Schulte

4

August 2023

Olaparib and Temozolomide

Later Line Treatment of Uterine LMS

Aug 14, 2023 • 

Brian Schulte

2

July 2023

Trends in FDA Approvals for Sarcoma

Where are we going?

Jul 8, 2023 • 

Brian Schulte

5

June 2023

Second Opinions

Getting the best information

Jun 18, 2023 • 

Brian Schulte

3

The Cisplatin Shortage

How does it affect treatment?

Jun 12, 2023 • 

Brian Schulte

1

How I discuss treatment of desmoid tumors

A patient-centered approach

Jun 9, 2023 • 

Brian Schulte

1

Reflections on ASCO 2023

The need for more Randomized Controlled Trials

Jun 6, 2023 • 

Brian Schulte

2

A few ASCO Abstracts

A small selection (there will be more)

Jun 1, 2023 • 

Brian Schulte

1

May 2023

Doxorubicin

History and Discovery

May 29, 2023 • 

Brian Schulte

4

Imatinib Side Effects

Diagnosis and Management of Common Symptoms

May 27, 2023 • 

Brian Schulte

1

Chemoimmunotherapy for Sarcoma

Doxorubicin and Pembrolizumab

May 23, 2023 • 

Brian Schulte